Found: 9
Select item for more details and to access through your institution.
Effectiveness of Casirivimab and Imdevimab Antibody Combination in Immunocompromised Hospitalized Patients With Coronavirus Disease 2019: A Post Hoc Analysis in a Phase 1/2/3 Double–Blind Trial.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 5, p. 1, doi. 10.1093/ofid/ofad211
- By:
- Publication type:
- Article
Effectiveness of Subcutaneous Casirivimab and Imdevimab in Ambulatory Patients with COVID-19.
- Published in:
- Infectious Diseases & Therapy, 2022, v. 11, n. 6, p. 2125, doi. 10.1007/s40121-022-00691-z
- By:
- Publication type:
- Article
Evaluation of Intravitreal Aflibercept for the Treatment of Severe Nonproliferative Diabetic Retinopathy: Results From the PANORAMA Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Alterations in tumor necrosis factor-induced endothelial cell procoagulant activity by hyperthermia.
- Published in:
- International Journal of Cancer, 2004, v. 111, n. 3, p. 457, doi. 10.1002/ijc.20272
- By:
- Publication type:
- Article
Compassionate Use of REGEN-COV® in Patients With Coronavirus Disease 2019 (COVID-19) and Immunodeficiency-Associated Antibody Disorders.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. e509, doi. 10.1093/cid/ciab1059
- By:
- Publication type:
- Article
Interleukin-1β induced vascular permeability is dependent on induction of endothelial Tissue Factor (TF) activity.
- Published in:
- Journal of Translational Medicine, 2005, v. 3, p. 37, doi. 10.1186/1479-5876-3-37
- By:
- Publication type:
- Article
Association of High Serum Interleukin‐6 Levels With Severe Progression of Rheumatoid Arthritis and Increased Treatment Response Differentiating Sarilumab From Adalimumab or Methotrexate in a Post Hoc Analysis.
- Published in:
- Arthritis & Rheumatology, 2020, v. 72, n. 9, p. 1456, doi. 10.1002/art.41299
- By:
- Publication type:
- Article
Human Monoclonal Antibody Cocktail for the Treatment or Prophylaxis of Middle East Respiratory Syndrome Coronavirus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Casirivimab + imdevimab accelerates symptom resolution linked to improved COVID-19 outcomes across susceptible antibody and risk profiles.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-39681-7
- By:
- Publication type:
- Article